Canadian stronghold Pharmascience is the largest pharmaceutical employer in Quebec with a substantial Canada-based footprint and growing global distribution, signaling strong domestic demand and potential expansion opportunities with Canadian healthcare providers and distributors.

R&D investment With annual R&D investment of 40-50 million and a top-100 ranking in Canada, there is an opportunity to position premium partnerships, contract manufacturing for new formulations, or co-development ventures with your sales team targeting innovative drug projects.

Regulatory launches Frequent product launches across generics and specialty areas (ritonavir? rupatadine, tofacitinib, apremilast) indicate a cadence of new-to-market products, suggesting sales potential in supply chain partners, packaging, and compliant manufacturing capabilities for timely market entry.

Global reach Distribution in over 50 countries combined with a privately owned structure offers a pathway for international supply agreements, export-oriented packaging services, and regional distribution collaborations to scale across emerging markets.

Patient support Programs like MyRx Care and equitable patient assistance highlight a willingness to invest in access initiatives; formulate value-based offerings such as patient access programs, co-pay support, and tailored pricing strategies to expand uptake and loyalty.